Beta-adrenergic blockade has been shown to improve left ventricular function , reduce hospital admissions and improve survival in chronic heart failure with reduced ejection fraction ( HFrEF ) , with mortality reduction starting early after beta-adrenergic receptor blocker initiation and being dose-related .